These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 21945739

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 23. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN, Robins E, Flament MP.
    Eur J Pharm Biopharm; 2012 Apr 15; 80(3):596-603. PubMed ID: 22198291
    [Abstract] [Full Text] [Related]

  • 24. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 15; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 25. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM, Wood O, Ooi J, Traini D.
    Int J Pharm; 2011 Sep 15; 416(1):129-35. PubMed ID: 21708238
    [Abstract] [Full Text] [Related]

  • 26. Influence of carrier surface fines on dry powder inhalation formulations.
    Boshhiha AM, Urbanetz NA.
    Drug Dev Ind Pharm; 2009 Aug 15; 35(8):904-16. PubMed ID: 19466888
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.
    Kaialy W, Nokhodchi A.
    AAPS J; 2013 Jul 15; 15(3):728-43. PubMed ID: 23591748
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 15; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

  • 30. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H, Markefka P, teWierik H, Kammelar R.
    Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105
    [Abstract] [Full Text] [Related]

  • 31. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN, Bierend H, Robins E, Steckel H, Flament MP.
    Int J Pharm; 2012 Jan 17; 422(1-2):75-82. PubMed ID: 22036653
    [Abstract] [Full Text] [Related]

  • 32. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    J Pharm Pharmacol; 2000 Oct 17; 52(10):1211-21. PubMed ID: 11092565
    [Abstract] [Full Text] [Related]

  • 33. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Oct 17; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 34. The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance.
    Jones MD, Santo JG, Yakub B, Dennison M, Master H, Buckton G.
    Int J Pharm; 2010 May 31; 391(1-2):137-47. PubMed ID: 20211715
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 31; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 36. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 37. The influence of carrier morphology on drug delivery by dry powder inhalers.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    Int J Pharm; 2000 Apr 25; 200(1):93-106. PubMed ID: 10845690
    [Abstract] [Full Text] [Related]

  • 38. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M, Kappl M, Butt HJ, Urbanetz NA, Lippold BC.
    Eur J Pharm Biopharm; 2007 Sep 25; 67(2):579-86. PubMed ID: 17418548
    [Abstract] [Full Text] [Related]

  • 39. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
    Kubavat HA, Shur J, Ruecroft G, Hipkiss D, Price R.
    Int J Pharm; 2012 Jul 01; 430(1-2):26-33. PubMed ID: 22449413
    [Abstract] [Full Text] [Related]

  • 40. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
    Ooi J, Traini D, Hoe S, Wong W, Young PM.
    Int J Pharm; 2011 Jul 15; 413(1-2):1-9. PubMed ID: 21501674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.